On the other hand, Andrews et al., in a population of 337 kidney transplant recipients, observed that CYP3A5 expressers had a significantly higher TAC clearance, while CYP3A4*22 carriers had a significantly lower clearance [48], as confirmed by Zuo and colleagues [49] (Table 1). The gene discussed is CYP3A5; the disease is kidney transplant.